After almost two decades of misguided policies based entirely upon pharmaceutical propaganda, the NIH and CDC have convinced the Obama Administration to ask state officials to drop the criminal prosecution of allegedly HIV+ Americans. This decision comes only nine months after OMSJ began to force prosecutors to prove that HIV tests detect HIV. Continue reading ‘OMSJ Prompts Nat’l HIV Policy Change in Nine Months’
Tag Archive for 'NIH'
The word is chutzpa – and it’s hard to imagine a better way to describe UC Berkeley (UCB) Vice Provost Sheldon Zedeck’s assignment of Arthur Reingold to investigate misconduct allegations against Professor Peter Duesberg, PhD. The charges stem from Duesberg’s (et al) report that was published in 2009 by Medical Hypotheses. Citing 35 references that includes South Africa’s (SA) own mortality reports, Prof. Duesberg’s team concluded that: Continue reading ‘The Berkeley Inquisition Exposed’
AHRP reports that history is about to repeat itself:
In the 1976 swine flu vaccine program, 40 million people were vaccinated with an inadequately tested vaccine. The government gave the vaccine manufacturers immunity from liability, but created an alternative compensation program. Five thousand people sought benefits for vaccine injuries.
Today, as in 1976, official concern has focused on flu vaccine availability without regard for the safety of an H1N1 vaccine. Many national regulatory agencies have set-up fast-track approval processes for the H1N1 vaccine, which means that a vaccine might be licensed without the usual safety and efficacy data requirements. Vaccine safety will therefore have to be monitored through post-marketing surveillance.
But there is reason for concern that we will repeat the debacle of the 1976 H1N1 outbreak in the USA, where mass vaccination was associated with complications, which stopped the campaign and led to the withdrawal of the vaccine.
What’s more, today, the government has NOT established an ALTERNATIVE COMPENSATION PROGRAM – as it had in 1976. The existing vaccine compensation program covers only designated vaccines and does NOT cover most adult vaccines.
The U.S. government has adopted (what critics regard) a reckless policy encouraging (if not mandating) the use of untested controversial vaccines with novel adjuvants likely to be used to strengthen vaccines and stretch the supply–they are named MF59 (Novartis) and ASO3 (Glaxo Smith-Kline). Only 3 vaccines using these adjuvants have been licensed in Europe, and none have been given a license in the US.
It is likely that these adjuvants will cause far more damage and autoimmune illness than the swine vaccine used in 1976.
Indeed, manufacturers have been given immunity from liability, as have the government program planners. But no compensation mechanism has been created for citizens who are likely to suffer harm. This is but a tacit acknowledgement that the vaccines are likely to produce harm.
The New York Times reports that pharmaceutical company ghostwriters played a major role in producing 26 scientific papers that backed the use of hormone replacement therapy in women, suggesting that the level of hidden industry influence on medical literature is broader than previously known.
The articles, published in medical journals between 1998 and 2005, emphasized the benefits and de-emphasized the risks of taking hormones to protect against maladies like aging skin, heart disease and dementia. That supposed medical consensus benefited Wyeth, the pharmaceutical company that paid a medical communications firm to draft the papers, as sales of its hormone drugs, called Premarin and Prempro, soared to nearly $2 billion in 2001.
But the seeming consensus fell apart in 2002 when a huge federal study on hormone therapy was stopped after researchers found that menopausal women who took certain hormones had an increased risk of invasive breast cancer, heart disease and stroke. A later study found that hormones increased the risk of dementia in older patients.
The ghostwritten papers were typically review articles, in which an author weighs a large body of medical research and offers a bottom-line judgment about how to treat a particular ailment. The articles appeared in 18 medical journals, including The American Journal of Obstetrics and Gynecology and The International Journal of Cardiology.
The articles did not disclose Wyeth’s role in initiating and paying for the work. Elsevier, the publisher of some of the journals, said it was disturbed by the allegations of ghostwriting and would investigate.
The documents on ghostwriting were uncovered by lawyers suing Wyeth and were made public after a request in court from PLoS Medicine, a medical journal from the Public Library of Science, and The New York Times.
A spokesman for Wyeth said that the articles were scientifically accurate and that pharmaceutical companies routinely hired medical writing companies to assist authors in drafting manuscripts. (Story here)
Although the reporting of this story by the NYT is new, the practice is not. According to former Eli Lilly marketing executive John Virapen, fake stories and reports are part of the overall marketing strategy throughout the pharmaceutical industry. Because the industry funds the FDA, CDC and NIH officials, no one investigates the corruption because they profit from them.
As a result, thousands of people are unnecessarily killed or injured from adverse drug reactions. In the case of Prozac or hormone replacement therapy, the eventual lawsuits are merely part of the cost of doing business. If a drug like Prozac generates $10 billion in profits over 20 years and generates $4 billion in lawsuits (with confidentiality agreements), the $6 billion net profit makes it worthwhile.
The problem is not that the pharmaceutical industry harms and kills patients millions of patients for profit, but that there are no competent investigative agencies or politicians who aren’t paid to ignore the mayhem.
In this related story, pharmaceutical lobbyists have successfully pressured White House officials to stand by their behind-the-scenes deal to block Congressional efforts to extract more than their agreed-upon $80 billion.
When the survival of South Africa’s (SA) mining industry now appears to hinge on their ability to blame their laborers’ costly mine-related lung diseases on irresponsible sex, the financial connections between South Africa’s mining industry, government regulators and university researchers is becoming clear.
Because strategic mining operations depend upon our ability to cheaply mine defense materials like gold, platinum and uranium, the US government shares a powerful incentive to promote the “irresponsible sex/HIV” mythology rather than support the historical claims against the SA mining industry.
Starling new evidence that AIDS denialist Peter Duesberg and his supporters may be liable for vast human tragedy. I hope that other denialists including Gil and Ullberg will read this carefully. I hope Gil and his gang will repent. Time may already have run out.
From 1999 to 2007, (Thabo) Mbeki and his Minister of Health Manto Tshabalala-Msimang obstructed and then undermined the implementation of highly active ARV treatment (HAART) and prevention of mother-to-child transmission of HIV in the public health system. Two studies, conducted independently of each other, conservatively calculated that over 300,000 people died because of Mbeki’s AIDS denialist policies.
Edward Mabunda was one of them. These studies could not account for additional deaths due to the promotion of quackery, often with the health minister’s support. They also did not consider the number of infections that occurred because of the confusion generated by the insipid state-funded prevention campaign and the messages by some outspoken Mbeki supporters dismissing the link between sex and HIV infection. The Mbeki era also fostered a profound mistrust of scientific medicine, the consequences of which also cannot be quantified.
What, if any, repercussions should be there for those responsible for this tragedy?
Geffen ponders various possible criminal charges and venues citing studies, all written by South African researchers who just happen to also be directly or indirectly funded by the SA mining industry, US pharmaceutical companies, investors and/or consultants to those industries. Some of those reports are published by the National Institutes of Health.
As I described last month, RMIT professor Jock McCulloch used portions of the Leon Commission Report (1995) to explain the incestuous relationships between the SA mining industry and research community which:
… shared the same research focus and a common source of funding through mine revenue. They also shared the same personnel, as key researchers moved between one sector and the other. The same men served on state commissions and departmental committees, and represented the Chamber at public inquiries. That made it difficult for an individual to confront the mining houses over the dust hazard…
While the slippery relationships between the genocidal post-Apartheid groups AIDS Truth, Treatment Action Campaign and the pharmaceutical industry and investors were exposed last month, Murtagh’s latest email and Geffen’s report produce one more financial/pharmaceutical connection.
The report footer indicates that it was published by the newly created Journal of Acquired Immune Deficiancy Syndrome (JAIDS.org), which is managed by co-Editors in Chief William Blattner (who just happens to be the co-founder of Robert Gallo’s Institute of Human Virology) and acclaimed AIDS researcher David Ho.
According to WK’s 2008 Annual Report:
Wolters Kluwer had 2008 annual revenues of €3.4 billion, employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America…
The division is organized into four market-centered business units – Pharma Solutions, Medical Research, Professional & Education, and Clinical Solutions – to serve the information needs of its customers.
Their product Pharma Solutions:
… provides a wide range of data and analytic capabilities, marketing and publication services, business intelligence products, and diversified consulting services to support life science professionals and the pharmaceutical industry, from drug discovery through distribution, as well as government agencies and other healthcare sectors…
… The unit was awarded multi-year pharmaceutical data contracts, including a long-term agreement with the U.S. Food and Drug Administration (FDA)… and a multi-year partnership with Bristol-Myers Squibb to provide Health Insurance Portability and Accountability Act (HIPAA) – compliant prescription sales data to measure business efficiency, control costs, and determine sales force effectiveness.
Bristol-Myers Squibb (BMS) is the manufacturer of Sustiva (Efavirenz), which is so highly addictive that African children are now smoking it like crack. Sustiva’s addiction-withdrawal syndrome also appears to produce symptoms that AIDS clinicians identify as the onset of AIDS.
Because BMS faces significant liability regarding the Sustiva snafu, they have good reason to partner with a damage-control publishing company like WK and children of Apartheid like Nathan Geffen who, with the assistance of very creative legal counsel (probably from WK), threatens real scientists like Peter Duesberg with false charges of genocide.
As an investigator, Geffen’s commentary appears to be one more propaganda piece that fits well with the genocidal post-Apartheid organizations that exploit Africa’s cheap black labor force for mining operations, leaving them with mining diseases, false HIV diagnoses and highly addictive and deadly AIDS drugs.
It is also possible that Geffen’s propaganda is the beginning of fabricated documentary evidence that Murtagh and his co-defendants may try to use to defend themselves from Ms. Farber’s lawsuit – even as they try to distance themselves from him.
Either way, Bristol-Myers Squibb has much to explain.